SEC Filing Summary: Clover Health Investments, Corp. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Clover Health Investments, Corp. on June 26, 2024. The filing addresses a specific corporate event regarding the company's listing status on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes
- Nasdaq Compliance: On June 26, 2024, the Company received written notice from The Nasdaq Stock Market confirming it has regained compliance with the minimum stock price requirement.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding future compliance with Nasdaq listing requirements. Management cautions that these statements are not guarantees and are subject to risks and uncertainties that could cause actual results to differ materially. The document references the Company's latest Annual Report on Form 10-K (filed March 14, 2024) for a comprehensive list of risk factors.
Investor Verification Checklist
- Verify the current trading price of Class A Common Stock (Symbol: CLOV) to confirm sustained compliance with Nasdaq minimum bid price rules.
- Review the press release filed as Exhibit 99.1 for additional details on the compliance notice.
- Consult the most recent Form 10-K for detailed financial performance and risk factors not included in this 8-K.